WO2009144977A1 - Composition orale pour la pousse des cheveux - Google Patents
Composition orale pour la pousse des cheveux Download PDFInfo
- Publication number
- WO2009144977A1 WO2009144977A1 PCT/JP2009/053091 JP2009053091W WO2009144977A1 WO 2009144977 A1 WO2009144977 A1 WO 2009144977A1 JP 2009053091 W JP2009053091 W JP 2009053091W WO 2009144977 A1 WO2009144977 A1 WO 2009144977A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hair
- composition
- sialic acid
- oral
- hair growth
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 230000003779 hair growth Effects 0.000 title claims abstract description 58
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims abstract description 82
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 claims abstract description 57
- 230000037406 food intake Effects 0.000 claims abstract description 10
- 235000013305 food Nutrition 0.000 claims description 28
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 210000004798 organs belonging to the digestive system Anatomy 0.000 abstract description 6
- 230000007794 irritation Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 description 24
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 21
- 102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 description 21
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 17
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 17
- 239000003795 chemical substances by application Substances 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 9
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 9
- 230000037396 body weight Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000002778 food additive Substances 0.000 description 6
- 235000013373 food additive Nutrition 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 201000004384 Alopecia Diseases 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- -1 absorption promoters Substances 0.000 description 4
- 235000017663 capsaicin Nutrition 0.000 description 4
- 229960002504 capsaicin Drugs 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 230000003676 hair loss Effects 0.000 description 4
- 208000024963 hair loss Diseases 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- FDJKUWYYUZCUJX-UHFFFAOYSA-N N-glycolyl-beta-neuraminic acid Natural products OCC(O)C(O)C1OC(O)(C(O)=O)CC(O)C1NC(=O)CO FDJKUWYYUZCUJX-UHFFFAOYSA-N 0.000 description 3
- 210000001099 axilla Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 235000013345 egg yolk Nutrition 0.000 description 3
- 210000002969 egg yolk Anatomy 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 3
- 235000008696 isoflavones Nutrition 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 210000003594 spinal ganglia Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000003813 thin hair Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 3
- 229960001600 xylazine Drugs 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- SQVRNKJHWKZAKO-LUWBGTNYSA-N N-acetylneuraminic acid Chemical class CC(=O)N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-LUWBGTNYSA-N 0.000 description 2
- SUHQNCLNRUAGOO-UHFFFAOYSA-N N-glycoloyl-neuraminic acid Natural products OCC(O)C(O)C(O)C(NC(=O)CO)C(O)CC(=O)C(O)=O SUHQNCLNRUAGOO-UHFFFAOYSA-N 0.000 description 2
- FDJKUWYYUZCUJX-KVNVFURPSA-N N-glycolylneuraminic acid Chemical compound OC[C@H](O)[C@H](O)[C@@H]1O[C@](O)(C(O)=O)C[C@H](O)[C@H]1NC(=O)CO FDJKUWYYUZCUJX-KVNVFURPSA-N 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000003656 anti-hair-loss Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000019685 rice crackers Nutrition 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- NCMJSVDTRDLWJE-LUWBGTNYSA-N (1R,2R,3S,7R)-2-acetamido-7-[(1R)-1,2-dihydroxyethyl]-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid Chemical compound O1C2(C(O)=O)C[C@H](O)[C@@H](NC(C)=O)[C@]1([H])[C@@H]([C@H](O)CO)O2 NCMJSVDTRDLWJE-LUWBGTNYSA-N 0.000 description 1
- FCPYDHZOFFVRHL-XMFCUXLASA-N (2R,3R,4S)-3-amino-4-hydroxy-2-[(2S)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid Chemical compound N[C@@H]1[C@@H](O)C=C(O[C@H]1C(O)[C@@H](O)CO)C(O)=O FCPYDHZOFFVRHL-XMFCUXLASA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 238000011891 EIA kit Methods 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- WZMUWVWBWABXLP-NDTUDMFWSA-N NC1C(C(O)=O)(O)O[C@H]([C@@H]([C@H]1O)N)[C@H](O)[C@H](O)CO Chemical compound NC1C(C(O)=O)(O)O[C@H]([C@@H]([C@H]1O)N)[C@H](O)[C@H](O)CO WZMUWVWBWABXLP-NDTUDMFWSA-N 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000015336 Nerve Growth Factor Human genes 0.000 description 1
- 101710122871 Skin calcitonin gene-related peptide Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- ZICNYIDDNJYKCP-SOFGYWHQSA-N capsiate Chemical compound COC1=CC(COC(=O)CCCC\C=C\C(C)C)=CC=C1O ZICNYIDDNJYKCP-SOFGYWHQSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- CLRLHXKNIYJWAW-QBTAGHCHSA-N deaminoneuraminic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@@H]1OC(O)(C(O)=O)C[C@H](O)[C@H]1O CLRLHXKNIYJWAW-QBTAGHCHSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- BQINXKOTJQCISL-GRCPKETISA-N keto-neuraminic acid Chemical compound OC(=O)C(=O)C[C@H](O)[C@@H](N)[C@@H](O)[C@H](O)[C@H](O)CO BQINXKOTJQCISL-GRCPKETISA-N 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000007758 minimum essential medium Substances 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- VWMVAQHMFFZQGD-UHFFFAOYSA-N p-Hydroxybenzyl acetone Natural products CC(=O)CC1=CC=C(O)C=C1 VWMVAQHMFFZQGD-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- NJGBTKGETPDVIK-UHFFFAOYSA-N raspberry ketone Chemical compound CC(=O)CCC1=CC=C(O)C=C1 NJGBTKGETPDVIK-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 125000005629 sialic acid group Chemical group 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Definitions
- the present invention relates to a composition for oral hair restoration.
- this invention relates to the composition for oral hair growth which contains sialic acid as an active ingredient and has a hair growth effect.
- hair growth agents have been developed so far, most of which are rubbed into the scalp and gained its effectiveness through penetration from the scalp. Such a usage method is difficult to use easily and makes it difficult to continue using it. In addition, many of them are traded at a high price, which places a burden on the therapist in terms of cost.
- a hair growth agent that is orally administered or ingested has also been developed.
- anti-hair loss symptom food and drink containing oolong tea extract containing oolong tea extract
- oral anti-hair loss symptom agent Patent Document 1
- hair growth food containing proanthocyanidins Patent Document 2
- Non-patent Document 3 capsaicin is a substance that temporarily gives severe irritation to the digestive organs such as the stomach and esophagus, and depending on the person, the digestive organs such as the stomach may be affected by ingestion.
- capsaicin is a substance that temporarily gives severe irritation to the digestive organs such as the stomach and esophagus, and depending on the person, the digestive organs such as the stomach may be affected by ingestion.
- due to the stimulation there is a problem that it is difficult to ingest unless it is ingested with a large amount of water.
- JP-A-9-309840 Japanese Patent Laid-Open No. 2000-201650 Japanese Patent Laying-Open No. 2005-068129 Naoaki Harada et al., Growth Hormone & IGF Research 17 (2007) 408-415
- An object of the present invention is to provide an oral hair-growth composition that has an excellent hair-growth effect and does not cause intense irritation to the digestive organs upon administration or ingestion.
- the present inventors can obtain an excellent hair-growth effect by oral administration or ingestion of sialic acid, and are accompanied by irritation to the digestive organs even when oral administration or ingestion of sialic acid.
- the inventors have found that the present invention can solve the above-mentioned problems.
- the present invention includes the following oral hair restoration compositions, hair restoration methods, oral hair restoration agents and the like according to items 1 to 19 below.
- Item 1. An oral hair restoration composition comprising sialic acid and a pharmaceutically acceptable or ingestible carrier.
- Item 2. The composition for oral hair restoration according to Item 1, wherein the sialic acid is N-acetylneuraminic acid.
- Item 3. The composition for oral hair restoration according to Item 1 or 2, comprising 0.1 to 95% by weight of sialic acid.
- Item 4. Item 4. The composition for oral hair restoration according to any one of Items 1 to 3, which is administered or ingested in an amount of 0.01 to 1000 mg / kg (body weight) per day for an adult.
- Item 5. Item 5.
- Item 5. The composition for oral hair restoration according to any one of Items 1 to 4, which is a food composition.
- Item 7. A method for hair growth comprising the step of orally administering or ingesting a person who desires hair growth with an amount of sialic acid effective for hair growth.
- Item 8. The hair growth method according to Item 7, wherein the sialic acid is N-acetylneuraminic acid.
- sialic acid is administered or ingested in an amount of 0.01 to 1000 mg / kg (body weight) per day.
- Item 10. Use of sialic acid for the production of a composition for oral hair restoration.
- Item 11. Item 11. The use according to Item 10, wherein the sialic acid is N-acetylneuraminic acid.
- Item 12. Sialic acid for hair growth by oral administration or ingestion.
- Item 13. N-acetylneuraminic acid for hair growth by oral administration or ingestion.
- Item 14. Item 5. The oral hair growth composition according to any one of Items 1 to 4, which is a food additive for hair growth.
- Item 16. Item 16.
- Item 17. Item 17.
- Item 18. An oral hair restorer comprising a food composition containing sialic acid.
- Item 19. An oral hair restorer comprising a food composition containing sialic acid.
- CGRP calcitonin gene-related peptide
- IGF-I insulin-like growth factor-I
- an oral hair growth composition an oral hair growth agent, and a hair growth method that have an excellent hair growth effect and that do not cause irritation to the digestive organs by oral administration or ingestion.
- the hair-growth effect refers to the effect of growing hair, and the effect of growing hair such as thickening, lengthening, strengthening, making it difficult to remove, and growing (stretching) the hair.
- the present invention is particularly excellent in the effect of growing hair.
- composition for oral hair restoration according to the present invention is characterized by containing sialic acid as an active ingredient.
- Sialic acid is a generic name for substances in which the amino group or hydroxy group of neuraminic acid is substituted.
- the sialic acid used in the composition for oral hair restoration according to the present invention may be naturally derived or chemically synthesized.
- naturally-derived materials not only purified products but also crude products can be used as long as the effects of the present invention can be obtained.
- Examples of naturally derived substances containing a large amount of sialic acid include axilla, milk, egg yolk and the like, and axilla is particularly preferable because of its high sialic acid content.
- milk and egg yolk are preferable from the ease of acquisition.
- Sialic acid can also be produced by, for example, an enzyme synthesis method using glucosamine as a raw material, a genetic engineering method using Escherichia coli, or the like, and these can also be used in the present invention.
- sialic acids can be used singly or in appropriate combination of two or more.
- composition for oral hair restoration according to the present invention contains, in addition to sialic acid, a pharmaceutically acceptable carrier or an ingestible carrier.
- the amount of sialic acid can be appropriately set according to the daily administration or intake amount, etc., but is preferably 0.01 to 99% by weight, more preferably 0.1 to 95% by weight based on the whole composition. 1 to 90% by weight is more preferable.
- the composition for oral hair restoration according to the present invention has an effect of inducing the release of calcitonin gene-related peptide (CGRP) and promoting the production of IGF-I within a range not losing the effects of the present invention. May be combined with sialic acid.
- IGF-I production promoting component include capsaicin, isoflavone, raspberry ketone, capsiate, honey, royal jelly, and the like. Among these, isoflavone is preferable.
- the compounding amount of the IGF-I production promoting component can be appropriately set according to the form of the oral hair growth composition according to the present application, the daily administration or intake amount, and the like.
- an IGF-I production promoting component By blending an IGF-I production promoting component, a synergistic hair growth effect with sialic acid can be expected. In particular, those blended at a ratio of 0.25 to 0.75 parts by weight of isoflavone to 1 part by weight of sialic acid are preferred, and those blended at 0.5 parts by weight are particularly preferred.
- the IGF-I production promoting component can be used alone or in combination of two or more in combination with sialic acid.
- composition for oral hair restoration according to the present invention, a pharmaceutically acceptable or ingestible carrier can be blended within a range that does not impair the effects of the present invention.
- Examples of pharmaceutically acceptable carriers include excipients, diluents, binders, disintegrants, stabilizers, absorption promoters, humectants, adsorbents, lubricants, and the like. Moreover, these agents can be illustrated as an ingestible carrier, for example. These carriers can be used singly or in appropriate combination of two or more.
- the fluorescent hair-growth composition according to the present invention can be blended with optional components as long as the effects of the present invention are not impaired.
- Such ingredients include, for example, antioxidants, coloring agents, sugar coatings, coating agents, pH regulators, emulsifiers, preservatives, sweeteners, preservatives, chewing agents, cooling agents, feeding accelerators, potentiators. Examples thereof include a sticky agent, a fragrance, a dispersant, and a miso odorant.
- optional components can be used singly or in appropriate combination of two or more.
- the oral hair growth composition according to the present invention is preferably, for example, a pharmaceutical composition or a food composition.
- the carrier to be blended is preferably pharmaceutically acceptable.
- the carrier is pharmaceutically acceptable or ingestible. Preferably there is.
- the shape of the composition for oral hair restoration according to the present invention is not particularly limited as long as it can be administered orally.
- it can be used as a liquid solution or as a solid tablet, powder, granule, powder or the like.
- such an oral hair growth composition can be used as a pharmaceutical composition or a food composition for hair growth.
- it can utilize also as a food additive for hair growth used by adding to food.
- the amount added to the food is appropriately set, and the food added with the food additive is eaten. Ingest.
- the said addition may be performed during food preparation or manufacture, and may be performed when eating the cooked food.
- Examples of such food additives include, but are not limited to, liquids, powders, flakes, granules, and pastes.
- composition for oral hair restoration according to the present invention is a food composition
- ingredients used as food may be blended within a range that does not impair the effects of the present invention. it can.
- the food composition include sialic acid-containing foods such as axilla, milk and egg yolk, various foods artificially containing sialic acid, and food compositions produced using these.
- the kind of food composition of this invention is not specifically limited, For example, drinks, confectionery (for example, gum, chocolate, candy, biscuits, cookies, rice crackers, rice crackers, etc.), breads, soups (powder soup, etc.) Etc.) can be exemplified.
- the food composition of the present invention can also be prepared as health foods (nutrient functional foods, foods for specified health use, etc.), supplements, foods for the sick, etc. for hair growth purposes.
- health foods nutrient functional foods, foods for specified health use, etc.
- supplements foods for the sick, etc. for hair growth purposes.
- the food composition of the present invention in order to facilitate continuous intake, for example, in the form of granules, capsules, tablets (including chewable agents), beverages (drinks), etc. It is desirable to prepare, and in particular, capsules, tablets, and tablets are preferable from the viewpoint of easy intake, but are not particularly limited thereto.
- the food and beverage composition of the present invention in the form of capsules and tablets can be appropriately prepared according to a conventional method using the pharmaceutically acceptable carrier. Moreover, even if it is a case where it prepares in another form, what is necessary is just to follow the conventional method.
- the composition for oral hair restoration according to the present invention can be administered or ingested for the purpose of hair restoration.
- humans who desire hair growth can be suitably used.
- humans who desire hair growth include those who suffer from hair loss and thinning hair, those who suffer from hair-related diseases such as alopecia, and those who have hair loss due to side effects of drugs.
- humans who desire further hair growth and hair growth can also be used without worrying about these symptoms.
- it can be applied not only to humans but also to pets, livestock and the like for which hair growth is desired. In this case, it can be used as a hair growth additive for pets and livestock medicines, solid and powdered feeds, and the like.
- the effective administration or intake for hair restoration of the composition for oral hair restoration according to the present invention is preferably 0.01 to 1000 mg / kg (body weight) / day in terms of sialic acid when used by an adult, and 0.1 to 100 mg. / kg (weight) / day is more preferable.
- the composition for oral hair restoration can be administered or ingested once or twice a day, and is preferably administered or ingested 1 to 3 times a day.
- the administration or intake of a child or pet who desires hair growth can be appropriately set according to the shape of the agent, the strength of the effect, and the like.
- the present invention also provides an oral hair restorer containing sialic acid as an active ingredient.
- the oral hair restorer can take, for example, the same form as that of the aforementioned oral hair restorer composition. Moreover, the said oral hair restorer may consist only of sialic acid.
- the present invention also provides a hair-growth method characterized by orally administering or ingesting sialic acid to a human suffering from hair loss or thinning hair, or a human who desires hair growth. Specifically, this method is carried out by administering or ingesting the above-mentioned composition for oral hair restoration.
- each condition such as the type of sialic acid, oral administration or intake is as described above.
- Test Example 1 Preparation of mouse dorsal root ganglion cells (DRG) 6- to 8-week-old C57BL / 6 male mice (Japan SLC) were prepared to be ketalal 100 mg / kg and xylazine 10 mg / kg. The mixture was administered intraperitoneally and anesthetized. The cervical vertebrae to lumbar vertebrae were removed, separated in the midline, and bilateral DRGs were collected.
- DRG mouse dorsal root ganglion cells
- the extracted DRG is put in 1.6 ml collagenase II (manufactured by GIBCO), 100 U / ml dispase I (manufactured by Godo Shusei), and 5% fetal bovine serum (FBS) -containing Minimum Essential Medium (manufactured by GIBCO) It was left overnight at 37 ° C., 5% CO 2 . After completion, the mixture was centrifuged at 3000 rpm and 25 ° C. for 5 minutes, and the supernatant was discarded. A nutrient solution having the following composition was added to the cells, stirred uniformly, and then cultured for 7 days at 37 ° C. and 5% CO 2 using a 35 mm dish (manufactured by BD Japan) coated with collagen I.
- DMEM / F-12 medium Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 mixed 1: 1) containing the following was used as a nutrient solution.
- Test Example 2 Effect of sialic acid on CGRP release from mouse dorsal root ganglion cells (DRG) After culturing DRG for 7 days as described in Test Example 1, the nutrient solution was discarded on the 7th day of culture, Replaced with DMEM / F-12 containing 1% FBS. N-acetylneuraminic acid (manufactured by Japan Food & Liquor Alliance) prepared so as to have final concentrations of 1, 10 and 100 mM was added thereto and left at 37 ° C. and 5% CO 2 for 30 minutes. After completion, the culture supernatant was collected and stored at -20 ° C. The CGRP concentration in the culture supernatant was measured using an ELISA kit (manufactured by SPI bio). The results are shown in FIG.
- DRG mouse dorsal root ganglion cells
- N-acetylneuraminic acid has an action of stimulating sensory nerves and releasing CGRP. It was also found that the higher the concentration of N-acetylneuraminic acid, the greater the amount of CGRP released (p ⁇ 0.01).
- composition for oral hair restoration according to the present application can be obtained by the production and release of CGRP.
- Test Example 3 Hair growth effect of sialic acid 6-week-old C57BL / 6 male mice (Japan SLC) were administered intraperitoneally with a mixture prepared to give ketalal 100 mg / kg and xylazine 10 mg / kg After anesthesia, the back was shaved with a size of 2 ⁇ 4 cm. Next, N-acetylneuraminic acid was dissolved in physiological saline so as to be 0.25 mg / ml and 0.5 mg / ml.
- mice forcibly administered once a day into the stomach of the aforementioned shaved mouse using a gastric sonde so as to be 0.1 ml per 10 g of body weight ie, the final dose was 2.5 mg / kg / day and 5 mg / day). kg / day).
- the control shaved mouse was administered with physiological saline so as to be 0.1 ml per 10 g of body weight.
- mice forcibly administered with these N-acetylneuraminic acids and the control mice forcibly administered with only saline were bred under the following conditions except for the forcible administration.
- the control mice have almost no hair on the shaved part, whereas the N-acetylneuraminic acid 2.5 mg / kg / day group has some hair and has a shaved part. Furthermore, in the 5 mg / kg / day administration group, hair was grown to such an extent that the shaved portion was hardly visible.
- Test Example 4 Effect of sialic acid on mouse skin calcitonin gene-related peptide (CGRP) and insulin-like growth factor-I (IGF-I) concentrations ⁇ Skin sample collection> N-acetylneuraminic acid was dissolved in physiological saline to a concentration of 0.5 mg / ml. Then, using a gastric sonde, this was forcibly administered once a day into the stomach of 6 to 8 week old C57BL / 6 male mice (5 mice) to 0.1 ml per 10 g of body weight (ie, the final dose was 5 mg / kg / day). Similarly, physiological saline was administered to the control group so as to be 0.1 ml per 10 g of body weight (5 animals).
- CGRP mouse skin calcitonin gene-related peptide
- IGF-I insulin-like growth factor-I
- mice forcibly administered with these N-acetylneuraminic acids and the control mice forcibly administered with only saline were bred under the conditions shown in Test Example 3 except for the forcible administration.
- the skin CGRP concentration in the N-acetylneuraminic acid administration group is about 2.5 times that of the control group, and the skin IGF-I concentration is about 3 times that of the control group. became.
- both the skin CGRP concentration and the skin IGF-I concentration were significantly higher in the N-acetylneuraminic acid administration group (p ⁇ 0.01).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne une composition orale qui présente une excellente efficacité pour la pousse des cheveux et pour laquelle l’administration ou l’ingestion n’est pas accompagnée d’une irritation sévère du tube digestif. L’invention concerne une composition orale pour la pousse des cheveux qui renferme de l’acide sialique et un support pharmacologiquement permissible et ingérable.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010514394A JPWO2009144977A1 (ja) | 2008-05-28 | 2009-02-20 | 経口育毛用組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008139525 | 2008-05-28 | ||
JP2008-139525 | 2008-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009144977A1 true WO2009144977A1 (fr) | 2009-12-03 |
Family
ID=41376865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2009/053091 WO2009144977A1 (fr) | 2008-05-28 | 2009-02-20 | Composition orale pour la pousse des cheveux |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2009144977A1 (fr) |
WO (1) | WO2009144977A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013522234A (ja) * | 2010-03-12 | 2013-06-13 | ディーエスエム アイピー アセッツ ビー.ブイ. | 母体へのシアル酸補給 |
CN104146885A (zh) * | 2014-07-14 | 2014-11-19 | 武汉中科光谷绿色生物技术有限公司 | N-乙酰神经氨酸水合物在育发产品中的应用 |
KR20170045275A (ko) * | 2014-10-31 | 2017-04-26 | 가부시키 가이샤 파마푸즈 | 발모 및 육모 촉진제 및 이들의 이용 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08119986A (ja) * | 1994-10-25 | 1996-05-14 | Nissin Food Prod Co Ltd | シアル酸またはその類縁体の精製方法 |
JP2001192393A (ja) * | 2000-01-07 | 2001-07-17 | Morinaga Milk Ind Co Ltd | 内在性シアリダーゼ耐性ラクトン体含有組成物 |
JP2009073806A (ja) * | 2007-08-27 | 2009-04-09 | Iriya Cosmetics Co Ltd | インスリン様成長因子−1分泌促進剤 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2555389B2 (ja) * | 1987-12-21 | 1996-11-20 | 雪印乳業株式会社 | 養毛剤 |
JP2006197914A (ja) * | 2005-01-21 | 2006-08-03 | Takeshi Inaba | 燕の巣入り飴及び燕の巣を混入した飴の製造方法 |
EP2157870A1 (fr) * | 2007-06-25 | 2010-03-03 | DSM IP Assets B.V. | Nouveaux prébiotiques |
-
2009
- 2009-02-20 WO PCT/JP2009/053091 patent/WO2009144977A1/fr active Application Filing
- 2009-02-20 JP JP2010514394A patent/JPWO2009144977A1/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08119986A (ja) * | 1994-10-25 | 1996-05-14 | Nissin Food Prod Co Ltd | シアル酸またはその類縁体の精製方法 |
JP2001192393A (ja) * | 2000-01-07 | 2001-07-17 | Morinaga Milk Ind Co Ltd | 内在性シアリダーゼ耐性ラクトン体含有組成物 |
JP2009073806A (ja) * | 2007-08-27 | 2009-04-09 | Iriya Cosmetics Co Ltd | インスリン様成長因子−1分泌促進剤 |
Non-Patent Citations (1)
Title |
---|
"Sialic acid", KAGAKU DAIJITEN 4, vol. 30TH PRI, 15 February 1987 (1987-02-15), pages 46 - 47 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013522234A (ja) * | 2010-03-12 | 2013-06-13 | ディーエスエム アイピー アセッツ ビー.ブイ. | 母体へのシアル酸補給 |
CN104146885A (zh) * | 2014-07-14 | 2014-11-19 | 武汉中科光谷绿色生物技术有限公司 | N-乙酰神经氨酸水合物在育发产品中的应用 |
KR20170045275A (ko) * | 2014-10-31 | 2017-04-26 | 가부시키 가이샤 파마푸즈 | 발모 및 육모 촉진제 및 이들의 이용 |
US10154684B2 (en) | 2014-10-31 | 2018-12-18 | Pharma Foods International Co., Ltd. | Hair regrowth and growth promoter and use thereof |
KR101966266B1 (ko) * | 2014-10-31 | 2019-04-05 | 가부시키 가이샤 파마푸즈 | 발모 및 육모 촉진제 및 이들의 이용 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2009144977A1 (ja) | 2011-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2548728C2 (ru) | Экстракт stevia или стевиол для ухода за волосами | |
KR102303570B1 (ko) | 에너지 소비의 촉진 및/또는 에너지 소비 기능 저하의 치료 및/또는 예방제, 또는 방법 | |
KR20080105023A (ko) | 근육 소모의 치료를 위한 기능성식품 조성물 | |
WO2011077800A1 (fr) | Agent permettant d'améliorer une hyperlipémie, composition permettant d'améliorer une anémie, composition permettant de réduire le taux d'acide urique et aliments et boissons | |
WO2011096414A1 (fr) | Agent d'amélioration de la fonction mitochondriale | |
JP5592640B2 (ja) | 乳酸菌発酵ローヤルゼリーを含有する抗ストレス剤、その製造方法、視床下部−下垂体−副腎皮質系の活動抑制剤、及び交感神経−副腎髄質系の活動抑制剤 | |
US20120309716A1 (en) | Motor Function Improver | |
JP2022079551A (ja) | 筋線維化抑制用組成物 | |
EP1767200A1 (fr) | Agent anti-vieillissement | |
WO2009144977A1 (fr) | Composition orale pour la pousse des cheveux | |
JP2019112328A (ja) | 概日リズム改善用組成物 | |
CN102273581A (zh) | 一种高甜度复配甜味剂 | |
EP4331601A1 (fr) | Composition alimentaire et composition pharmaceutique pour prévenir ou soulager la sarcopénie, contenant du collagène de faible poids moléculaire en tant que principe actif | |
JP5394644B2 (ja) | アスペルロシドまたはその類縁体を含む筋肉増強剤 | |
KR101660834B1 (ko) | 지페노사이드 75의 항당뇨 효과 | |
US20200163854A1 (en) | Life-extending agent, anti-aging agent, cosmetic, and food/beverage composition | |
WO2019146082A1 (fr) | Agent destiné à soulager un trouble du spectre autistique et une maladie mentale | |
JP6071988B2 (ja) | 身体活動促進剤 | |
KR20150131476A (ko) | 설포라판 유도체를 유효성분으로 함유하는 간질환 예방 및 치료용 조성물 | |
US20240207366A1 (en) | Food composition and pharmaceutical composition for preventing or alleviating sarcopenia, containing low-molecular-weight collagen as active ingredient | |
WO2010119804A1 (fr) | Agent anti-fatigue mentale | |
JP7503179B2 (ja) | インスリン抵抗性改善用組成物 | |
JP2011063552A (ja) | 身体活動促進剤 | |
JP7206623B2 (ja) | 糖代謝異常の予防および改善用組成物 | |
US11464824B2 (en) | Peptide capable of improving cognitive function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09754485 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010514394 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09754485 Country of ref document: EP Kind code of ref document: A1 |